Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug for treating neonatal jaundice

A newborn jaundice and drug technology, applied in the field of medicine, can solve the problems of long taking time, addiction, recurrent attacks, etc., and achieve the effect of short course of treatment, high efficiency and safe use

Inactive Publication Date: 2018-03-27
尚云
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, phototherapy is mostly used in the treatment of neonatal jaundice to reduce serum unconjugated bilirubin. However, since phototherapy must be treated in a hospital, it is difficult to widely promote it.
In conventional drug treatment, it is stubborn, has large side effects, takes a long time and recurs, and most of them are addictive. The relapse rate is high after drug withdrawal, and it cannot be cured

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] In the embodiment of the present invention, a medicine for the treatment of neonatal jaundice, according to parts by weight of raw materials includes: coix seed 80 parts, rhubarb 80 parts, flat bamboo root 5 parts, linoleum grass 5 parts, white fresh bark 5 parts, gardenia 5 parts, 5 parts of red peony root, 3 parts of Wangbuliu line, 3 parts of Platycladus orientalis, 5 parts of jujube, 1 part of licorice, 20 parts of branches, 5 parts of Guangyujin, 5 parts of Shenqu.

[0030] The medicine for the treatment of neonatal jaundice is prepared through the following steps: respectively weighing coix seed, rhubarb, flat bamboo root, lint grass, white fresh bark, gardenia, red peony root, Wang Buliu line and side Cypress leaves, jujube, licorice, branch, turmeric, divine song, mix and grind to make 80 mesh fine powder to obtain the medicine.

Embodiment 2

[0032] In the embodiment of the present invention, a medicine for treating neonatal jaundice, according to parts by weight of raw materials, includes: Coix Seed 350 parts, Rhubarb 300 parts, Flat Bamboo Root 40 parts, Kosmograss 40 parts, White Fresh Bark 45 parts, Gardenia 50 parts, 50 parts of red peony root, 30 parts of Wangbuliu line, 30 parts of arborvitae leaves, 30 parts of jujube, 30 parts of licorice, 200 parts of branches, 40 parts of turmeric, 40 parts of Shenqu.

[0033] The medicine for the treatment of neonatal jaundice is prepared through the following steps: respectively weighing coix seed, rhubarb, flat bamboo root, lint grass, white fresh bark, gardenia, red peony root, Wang Buliu line and side Cypress leaves, jujube, licorice, branch, turmeric, magic song are mixed and ground to make a 150-mesh fine powder to obtain the medicine.

Embodiment 3

[0035] In the embodiment of the present invention, a medicine for the treatment of neonatal jaundice, in terms of parts by weight of raw materials, includes: 85 parts of coix seed, 85 parts of rhubarb, 8 parts of bamboo root, 8 parts of linoleum grass, 8 parts of white fresh bark, gardenia 8 parts, 8 parts of red peony root, 4 parts of Wangbuliu line, 4 parts of Platycladus orientalis, 8 parts of jujube, 2 parts of licorice, 30 parts of branches, 8 parts of Guangyujin, 8 parts of Shenqu.

[0036] The medicine for the treatment of neonatal jaundice is prepared through the following steps: respectively weighing coix seed, rhubarb, flat bamboo root, lint grass, white fresh bark, gardenia, red peony root, Wang Buliu line and side Cypress leaves, jujube, licorice, branch, turmeric, divine song, mix and grind to make a fine powder of 100 mesh to obtain the medicine.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a drug for treating neonatal jaundice. The drug contains the following raw materials in parts by weight: 80-350 parts of coix seeds, 80-300 parts of rheum officinale, 5-40 parts of iris japonica thumb, 5-40 parts of spatulate sundew, 5-45 parts of cortex dictamni, 5-50 parts of fructus gardenia, 5-50 parts of radix paeoniae rubra, 3-30 parts of semen vaccariae, 3-30 parts of cacumen platycladi, 5-30 parts of Chinese dates, 1-30 parts of liquorice, 20-200 parts of fructus garedeniae, 5-40 parts of tuber of Curcuma Kwangsiensis and 5-40 parts of medicated leaven. The rawmaterial drugs adopted in the drug are wide in sources and safe in use and have not toxic and side effects; and the raw material formula is reasonable, the compatibility is scientific, both symptoms and root causes are considered, the treatment effect is definite, the effective rate is high, and the treatment course is short. The clinical application in several years proves that the total effective rate is 100%, the curing rate is above 85%, and patients with neonatal jaundice can be cured within 3-10 days.

Description

Technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating neonatal jaundice. Background technique [0002] Medically, the jaundice of newborns who are not full moon (within 28 days of birth) is called neonatal jaundice (neonataljaundice). Neonatal jaundice refers to the neonatal period. Due to abnormal bilirubin metabolism, the blood bilirubin level increases. , And the appearance of diseases characterized by yellowing of the skin, mucous membrane and sclera is the most common clinical problem in newborns. The disease is divided into physiological and pathological. Physiological jaundice refers to temporary jaundice caused solely by the characteristics of bilirubin metabolism. It appears in 2 to 3 days after birth, reaches a peak in 4 to 6 days, and subsides in 7 to 10 days. The duration of preterm infants is longer, except for mild Except for loss of appetite, there are no other clinical symptoms. If jaundice occ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61P1/16
CPCA61K36/00A61K36/14A61K36/185A61K36/36A61K36/484A61K36/65A61K36/708A61K36/71A61K36/725A61K36/744A61K36/75A61K36/88A61K36/8994A61K36/9066A61K2300/00
Inventor 尚云高渐联李晶郭锦辉黄倩
Owner 尚云
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com